IDiyas

For the Inventor, By the Inventor

Waukegan, IL, United States of America

James D Ratajczyk

USPTO Granted Patents = 8

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 87(Granted Patents)


Company Filing History:

goldMedal8 out of 4,177 
 
Abbott Laboratories Corporation
 patents

Years Active: 1976-1997

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5616596 - Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of (1997-04-01),
2. 5580989 - Process for the preparation of N-4-[(substituted phenyl)alkylheterocyclic]- (1996-12-03),
3. 5516647 - Compounds useful as alkaline phosphatase inhibitors and therapeutic (1996-05-14),
4. 5446055 - Polyether naphthalenic lignan lactones as inhibitors of 5-lipoxygenase (1995-08-29),
5. 5426111 - [Alkoxy-, alkenyloxy-, alkynyloxy-, and phenylmethyloxyalkoxycycloalkyl (1995-06-20),
6. 5288751 - [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] (1994-02-22),
7. 4476137 - [1-(2-Benzoxazolyl)hydrazino]alkyl nitrile derivatives (1984-10-09),
8. 3939161 - 1,3-Dimethyl- 1H-pyrazolo(4,3-D) pyrimidine-7 (6H)-ones (1976-02-17),

Title: Innovations and Contributions of James D Ratajczyk

Introduction

James D Ratajczyk is a notable inventor based in Waukegan, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for treating allergic and inflammatory diseases. With a total of 8 patents to his name, Ratajczyk's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents, Ratajczyk has developed inhibitors of the enzyme 5-lipoxygenase. These inhibitors are crucial for therapeutic applications in managing various allergic and inflammatory conditions. His innovative processes include the preparation of N-4-[(substituted phenyl)alkylheterocyclic] compounds and methods for synthesizing N-hydroxyurea compounds using palladium catalysts.

Career Highlights

Ratajczyk is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on groundbreaking research and development in pharmaceuticals. His contributions have been instrumental in advancing therapeutic options available to patients.

Collaborations

Throughout his career, Ratajczyk has collaborated with esteemed colleagues such as Anwer Basha and Clint D Brooks. These collaborations have fostered an environment of innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

James D Ratajczyk's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents that improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…